Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TV-45070 in Primary Knee Osteoarthritis
NCT02068599Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Apr 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of funapide in osteoarthritis (OA) (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Change From Baseline to Last 5 Days of Treatment in the Average Evening Pain Intensity In the Target Knee When Walking on a Flat Surface. Started Apr 2014; status: completed.
02
Drugs
funapide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02068599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068599.